In its 2022 Scientific Meeting, the NanoMedicines Innovation Network (NMIN) will gather its pan-Canadian teams of experts, their partners and collaborators, together with other stakeholders, to advance NMIN’s innovative research and commercialization strategies for the development, translation and clinical application of nanomedicine-based diagnostics and therapeutics to benefit patients, the national health research ecosystem, and the Canadian economy.
Participation in NMIN’s 2022 Scientific Meeting is restricted to network participants (researchers, trainees, committee members, partner representatives) and invited guests.
In its 2022 Scientific Meeting, the NanoMedicines Innovation Network (NMIN) will gather its pan-Canadian teams of experts, their partners and collaborators, together with other stakeholders, to advance NMIN’s innovative research and commercialization strategies for the development, translation and clinical application of nanomedicine-based diagnostics and therapeutics to benefit patients, the national health research ecosystem, and the Canadian economy.
Participation in NMIN’s 2022 Scientific Meeting is restricted to network participants (researchers, trainees, committee members, partner representatives) and invited guests.
In its 2022 Scientific Meeting, the NanoMedicines Innovation Network (NMIN) will gather its pan-Canadian teams of experts, their partners and collaborators, together with other stakeholders, to advance NMIN’s innovative research and commercialization strategies for the development, translation and clinical application of nanomedicine-based diagnostics and therapeutics to benefit patients, the national health research ecosystem, and the Canadian economy.
Participation in NMIN’s 2022 Scientific Meeting is restricted to network participants (researchers, trainees, committee members, partner representatives) and invited guests.
The first NMIN Trainee Symposium will provide NMIN HQP and members of the NMIN HQP Network (NHN) with unique value-added professional development opportunities, allowing for skill and knowledge acquisition to enhance career development and complement academic and scientific training.
The Symposium will also foster networking and collaboration among trainees and young professionals who share an interest in the field of nanotechnology-enabled drug delivery, gene therapy and diagnostics.
This is an in-person event.
This event immediately follows NMIN’s 2022 Scientific Meeting, being held at the same venue.
The first NMIN Trainee Symposium will provide NMIN HQP and members of the NMIN HQP Network (NHN) with unique value-added professional development opportunities, allowing for skill and knowledge acquisition to enhance career development and complement academic and scientific training.
The Symposium will also foster networking and collaboration among trainees and young professionals who share an interest in the field of nanotechnology-enabled drug delivery, gene therapy and diagnostics.
This is an in-person event.
This event immediately follows NMIN’s 2022 Scientific Meeting, being held at the same venue.